
Dec 22 (Reuters) - Scienture Holdings Inc SCNX.O:
SCIENTURE PROVIDES UPDATE ON THE COMMERCIAL LAUNCH OF REZENOPY®, THE HIGHEST STRENGTH NALOXONE HCL LIFE-SAVING OPIOID OVERDOSE EMERGENCY TREATMENT APPROVED BY THE FDA
SCIENTURE HOLDINGS INC - REZENOPY EXPECTED COMMERCIALLY AVAILABLE EARLY Q2 2026